RASHA KAFI: Open Payments
NPI 1154962231 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 18 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $299 · 2025 $569
Food & beverage: $387Education: $182
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 3 | $210 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| BeOne Medicines USA, Inc. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Incyte Corporation | 2 | $50 |
| Agios Pharmaceuticals, Inc. | 2 | $36 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
| SERVIER PHARMACEUTICALS LLC | 1 | $17 |
Products named: BRUKINSA, JAKAFI, PYRUKYND, KISQALI, ZEPZELCA, TAGRISSO, CABOMETYX, MONOFERRIC.
Industry payments across VA — which companies pay providers there.
